CBA Canada is the Canada chapter of CBA. CBA Canada’s primary mission is to bridge biopharmaceutics communications between US, Canada, and China. We work together to create a platform for easier collaboration and effective communications in the field of health sciences and the biopharmaceutical industry.

CBA is one of the largest Chinese American professional associations in the US. Founded in 1995, CBA is an independent, non-political, not-for-profit professional organization, with more than 8,000 members, of which over 80% have Ph.D. degrees. Many internationally renowned scientists including Nobel laureates, business leaders, and high-ranking US and Chinese government officials have attended and spoken at CBA’s annual conferences. CBA’s events and members have been covered by a number of prestigious scientific journals, business magazines, and news media such as Nature, Science, Thomson Reuters, China Central Television (CCTV), PR Newswire, BioPortfolio, and Bioprocess International.

CBA is headquartered in the Greater Washington area, which is the US’s leading biotech cluster. Many of CBA’s members work at renowned institutions, research facilities, biotech/pharmaceutical companies, and top universities in the world, including the FDA, National Institutes of Health, AstraZeneca/MedImmune, GlaxoSmithKline, Johns Hopkins University, George Washington University, Georgetown University, and University of Maryland.

With more than 20 years of persistent efforts towards promoting worldwide communication in the biopharmaceutical and health science industry, we brought together countless elites to share insights on the latest progress in global biopharmaceutical development. CBA has successfully held 25 annual conferences in the United States, Canada and China up to now. We have decided to expand our mission and anticipate holding the 2^nd CBA-Canada’s annual conference.